简介:目的:探讨超声乳化术治疗特殊类型白内障的安全性和有效性。方法:回顾性分析临床资料,研究超声乳化吸出(联合)人工晶状体植入术治疗青光眼术后白内障、小瞳孔白内障、葡萄膜炎并发白内障和外伤后并发白内障等特殊类型白内障的技术要领。结果:进行治疗的73例84眼特殊类型白内障患者中,单纯行超声乳化术27例28眼,植入后房型人工晶状体52眼,植入前房型人工晶状体4眼;术后1mo平均眼压12.72±2.63mmHg,脱盲率99%,脱残率96%;并发症发生率4%。结论:特殊类型白内障手术难度大,超声乳化术切口小,可保留晶状体后囊膜和植入人工晶状体,是摘除特殊类型白内障的理想术式。
简介:目的:通过对Q值调整非球面切削与标准化LASIK术后视觉质量的观察来分析Q值引导个性化切削技术的临床效果。方法:对2008-01/05等效球镜低于-12.00D的46例88眼进行非球面切削或标准化LASIK术后进行随访,按术前屈光度数将其分为A组(〈-6.00D)和B组(-6.00~-12.00D)两组,对比各组非球面切削与标准化LASIK术后1mo裸眼视力、Q值、夜间眩光、夜间视物质量及满意率(后3者采取问卷调查)。结果:A、B组内非球面切削与标准化LASIK术后裸眼视力差异无统计学意义(t=1.18,P〉0.05;t=0.62,P〉0.05);A、B组内非球面切削与标准化LASIK术后Q值差异无统计学意义(t=-0.93,P〉0.05;t=-0.372,P〉0.05);A组内非球面切削与标准化LASIK术后眩光、夜间视物质量差异无统计学意义(眩光:χ^2=2.397,P>0.05;夜间视物质量:χ2=1.263,P〉0.05);B组内非球面切削与标准化LASIK术后眩光、夜间视物质量差异有统计学意义(眩光:χ^2=10.85,P〈0.01;夜间视物质量:χ^2=10.85,P〈0.01);术后效果满意率达到98%。结论:非球面切削能明显改善-6.00D以上的术后主观视觉质量。
简介:目的分析Nd:YAG激光行后囊膜切开术治疗白内障复明手术后不同类型后发性白内障的治疗作用与术后并发症。方法对白内障复明手术后,109例(109眼)后发性白内障依据后囊昆浊形态分为:A组Elschnig珍珠样小体型46例(46眼),B组纤维化型63例(63眼)。采用十字形切开法或开罐式切开法进行激光后囊膜切开术,比较两组激光术前最佳矫正视力与激光术后最佳矫正视力以及激光术后并发症情况。结果A、B两组内激光术后最佳矫正视力较激光术前最佳矫正视力改善(P〈0.05);A组术后眼压升高和房水闪辉明显高于B组(P〈0.05)。结论Nd:YAG激光是治疗白内障复明手术后不同类型后发障的常用有效的治疗方法,激光术后并发症与后发性白内障类型有关。
简介:目的观察白内障冷冻囊内摘除术后二期人工晶状体植入疗效.方法对134例134眼白内障冷冻囊内摘除术后元晶状体眼随机分为两组,第一组弹性开放襻前房型人工晶状体植入组共70眼;第二组为后房型人工晶状体缝线固定组共66眼.结果两组病例术后矫正视力均达到术前矫正视力或超过,矫正视力0.5以上超过60%,两组病例视力差异元明显统计学意义.结论白内障囊内摘除术无晶状体眼两种类型人工晶状体二期植入均具有良好的治疗效果.
简介:AIM:ToinvestigatetheinterferingeffectofY-27632,aROCK-Iselectiveinhibitor,onthesignaltransductionpathwayoftransforminggrowthfactor-β1(TGF-β1)inocularTenoncapsulefibroblasts(OTFS)invitro.METHODS:AfterOTFSfrompassages4to6invitrowereinducedbyTGF-β1andthentreatedbyY-27632,thechangesoftheOTFScellcycleswereanalyzedviaflowcytometry,andtheproteinsexpressionoftheα-smoothmuscularactin(α-SMA),connectivetissuegrowthfactor(CTGF),collagenIwerecalculatedbyWesternblot.AfterOTFStreatedbythedifferentconcentrationsofY-27632,theexpressionlevelsoftheα-SMA,CTGFandcollagenImRNAwereassayedbyRT-PCR.RESULTS:Y-27632hadnomarkedlyeffectontheOTFScellcycles.AftertreatedbyTGF-β1,OTFSinG1periodsignificantlyincreased.ThecellcyclesdistributionbybothTGF-β1andY-27632hadnoremarkabledifferencefromthatincontrolgroup.Y-27632significantlyinhibitedtheproteinsexpressionsofbothα-SMAandCTGF,whiletosomeextentinhibitedthatofcollagenI.TGF-β1significantlypromotedtheproteinsexpressionsofα-SMA,CTGFandcollagenI.AfterOTFStreatedbybothTGF-β1andY-27632,ofα-SMA,theproteinexpressionwassimilarwiththatincontrolgroup(P=0.066>0.05),buttheproteinexpressionofCTGForcollagenI,respectively,wassignificantlydifferentfromthatincontrolgroup(P=0.000<0.01).Thedifferencesofexpressionsoftheα-SMA,CTGFandcollagenImRNAin30,150,750μmol/LY-27632groupwerestatisticallysignificant,comparedwiththoseincontrolgroup,respectively(α-SMA,P=0.002,0.000,0.000;CTGF,P=0.014,0.002,0.001;collagenI,P=0.003,0.002,0.000).CONCLUSION:BlockingtheRho/ROCKsignalingpathwaybyusingofY-27632couldinhibitthecellularproliferationandtheexpressionofbothCTGFandα-SMAwhateverOTFSinducedbyTGF-β1ornot.Y-27632suppressedtheexpressionofcollagenImRNAwithoutinduction.
简介:AIM:Toassesstheawarenessofeyecomplicationsandtheprevalenceofretinopathy,inthefirstvisittoeyeclinic,amongtype2diabeticpatientsattendingatertiarymedicalcentreinKualaLumpur,Malaysia.METHODS:Aninvestigator-administeredquestionnairewasgivento137patientswithdiabetesundergoingfirsttimeeyescreeningintheeyeclinic.Thiswasfollowedbyadetailedfundusexaminationbyaseniorophthalmologisttoassessforpresenceofretinopathy.RESULTS:Almost86%ofrespondentswereawareofdiabeticeyecomplications,especiallyinpatientswhohadachievedtertiaryeducationallevel(96.3%).Themajorityofthepatients(78.8%)werereferredbytheirphysiciansandonly20.4%cameontheirowninitiative.Manyofthepatients(43.8%)didnotknowhowfrequenttheyshouldgoforaneyecheck-upand72.3%didnotknowwhattreatmentswereavailable.Lackofunderstandingondiabeticeyediseases(68.6%)wasthemainbarrierformostpatientsfornotcomingforeyescreeningearlier.Despiteahighlevelofawareness,only21.9%hadrecordedHbA1clevelof<6.5%while31.4%wereundertheerroneousassumptionofhavingagoodbloodsugarcontrol.Atotalof29.2%haddiabeticretinopathyintheirfirstvisiteyetesting.CONCLUSION:Inthepresentstudy,29.2%oftype2diabeticpatientshadretinopathyintheirfirsttimeeyetesting.Althoughtheawarenessofdiabeticeyecomplicationswashighamongfirsttimeeyescreeningpatients,theappropriateeyecare-seekingbehaviorwascomparativelylessandshouldberectifiedtopreventtheriseofthissightthreateningeyedisease.
简介:AIM:ToinvestigatetheexpressionsoftypeIcollagen,α2integrinandβ1integrinintheposteriorscleraofguineapigswithdefocusmyopiaandwhetherbasicfibroblastgrowthfactor(bFGF)injectioninhibitstheformationanddevelopmentofmyopiabyupregulatingtheexpressionoftypeIcollagen,α2integrinandβ1integrin.METHODS:After14daysoftreatment,therefractivestateandaxiallengthweremeasuredandthelevelsoftypeIcollagen,α2integrinandβ1integrinwereassayedintheposteriorscleraeofgroupsofguineapigsthatworeamonocular-7Dpolymethylmethacrylate(PMMA)lensorhad-7DlenswearfollowedbytheperibulbarinjectionofPhosphateBufferSolution(PBS)orbFGF.Theuntreatedfelloweyeservedasacontrol.Guineapigswithnotreatmentservedasnormalgroup.·RESULTS:Theresultsshowedthat14daysofmonoculardefocusincreasedaxialeyelengthandrefraction,whilebFGFdeliveryinhibitedthemmarkedly.Further,itwasalsofoundthatthemonocular-7DlenscoulddecreasethelevelsoftypeIcollagen,α2integrinandβ1integrinexpressions,while,unlikePBS,bFGFincreasedthemsignificantlyincomparisontocontralateralcontroleyesandnormaleyes.CONCLUSION:bFGFcanpreventtheformationanddevelopmentofdefocusmyopiabyupregulatingtheexpressionsoftypeIcollagen,α2integrinandβ1integrin.Takentogether,ourresultsdemonstratethatbFGFpromotesscleraremodelingtopreventmyopiainguineapigs.